Mitsubishi Tanabe Pharma issues its news to provide stakeholders with the latest information related to the Company. Information on products or drug candidates may be included, but is intended to provide for the media, etc. It is not intended for promotion, advertising or medical advice. Information is current as of the date of issue of the individual news. Please be advised that information may be outdated after that point.

Information Mitsubishi Chemical Group ― Notice on Revision to Consolidated Financial Results Forecast for the Fiscal Year Ending March 31, 2023

February 16, 2023

The parent company of Mitsubishi Tanabe Pharma Corporation (Head Office: Osaka, Japan; Representative Director: Hiroaki Ueno), Mitsubishi Chemical Group Corporation (Head office: Chiyoda-ku, Tokyo; President: Jean-Marc Gilson) made the following announcement today.


Notice on Revision to Consolidated Financial Results Forecast for the Fiscal Year Ending March 31, 2023

URL:https://www.mcgc.com/english/news_release/pdf/01494/01730.pdf



Related information


News 2023

This website uses cookies to provide better content. By browsing this site, you accept our use of cookies.
Privacy Policy